Morgan Stanley raised target for Synopsys stock to USD 574

Published on 10/26/2026 at 12:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal third-quarter revenue rose 42.4 percent to USD 2.48 billion. Synopsys stock costs EUR 383.75, 0.58 percent below its EUR 386.00 Xetra close.

Analyst target and company growth

Morgan Stanley lifted its Synopsys target to USD 574 on October 20, 2026.
Fiscal third-quarter revenue rose 42.4 percent to USD 2.48 billion.
Synopsys stock trades at EUR 383.75 at 12:44 p.m. CEST at Lang & Schwarz on October 26, 2026, 0.58 percent below the Xetra close of October 23, 2026.
The company had a USD 82.4 billion market capitalization as of October 23, 2026.

Synopsys Inc., US8716071076, Illustration mit AI erstellt.

Synopsys Inc. (ISIN US8716071076) was trading at EUR 383.75 at Lang & Schwarz at 12:44 p.m. CEST on October 26, 2026, 0.58 percent below the Xetra close of October 23, 2026 at EUR 386.00. The latest analyst catalyst came on October 20, 2026, when Morgan Stanley raised its Synopsys price target from USD 500 to USD 574 and maintained an Overweight rating, as reported by MarketBeat.

Target rises as growth broadens

The target move followed a strong fiscal third quarter. Synopsys reported USD 2.48 billion in revenue for the quarter ended July 31, 2026, up 42.4 percent from the prior-year quarter, while diluted earnings per share were USD 2.84. The standardized quarterly figures show net income attributable to common shareholders of USD 545.8 million.

MarketBeat reported that Synopsys had also authorized a USD 1.0 billion share-repurchase program on October 5, 2026, covering up to 1.1 percent of outstanding shares. The combination gives the target revision two distinct supports: operating growth and capital returns.

Three dates frame the shift

On August 26, 2026, Synopsys published fiscal third-quarter results with USD 2.48 billion in revenue. On September 30, 2026, the company held its 2026 Investor Day and presented its longer-term strategy, according to the Synopsys corporate site. On October 20, 2026, Morgan Stanley raised its target from USD 500 to USD 574.

What does the target mean?

The revised target is a USD 74 increase, or 14.80 percent above Morgan Stanley previous target. MarketScreener listed 25 analysts in its October 2026 consensus, with an average target of USD 586.95 and a high target of USD 700.00, while the low target was USD 475.00.

Stock valuation remains elevated

Synopsys had a USD 82.4 billion market capitalization as of October 23, 2026. Its Nasdaq quote on that date was USD 430.14, with a 52-week range of USD 362.55 to USD 539.48. For investors, the central question is whether the latest revenue acceleration can support the higher expectations embedded in analyst targets.

Growth and valuation in view

At Lang & Schwarz, Synopsys was trading at EUR 383.75 on October 26, 2026 at 12:44 p.m. CEST, 0.58 percent below the Xetra close of October 23, 2026 at EUR 386.00. The further course of trading is shown by the continuously updated real-time quote of Synopsys stock.